An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection

ccJE+Advax is an inactivated cell culture Japanese encephalitis (JE) vaccine formulated with Advax, a novel polysaccharide adjuvant based on delta inulin. This vaccine has previously shown promise in murine and equine studies and the current study sought to better understand its mechanism of action...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tomoyoshi Komiya, Yoshikazu Honda-Okubo, Jeremy Baldwin, Nikolai Petrovsky
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	Japanese encephalitis vaccine singles dose protection flaviviruses antibody-dependent enhancement Advax Medicine R
Acceso en línea:	https://doaj.org/article/3410be75772e476ab3979476c60a7d80
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3410be75772e476ab3979476c60a7d80
record_format	dspace
spelling	oai:doaj.org-article:3410be75772e476ab3979476c60a7d802021-11-25T19:10:21ZAn Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection10.3390/vaccines91112352076-393Xhttps://doaj.org/article/3410be75772e476ab3979476c60a7d802021-10-01T00:00:00Zhttps://www.mdpi.com/2076-393X/9/11/1235https://doaj.org/toc/2076-393XccJE+Advax is an inactivated cell culture Japanese encephalitis (JE) vaccine formulated with Advax, a novel polysaccharide adjuvant based on delta inulin. This vaccine has previously shown promise in murine and equine studies and the current study sought to better understand its mechanism of action and assess the feasibility of single dose vaccine protection. Mice immunised with ccJE+Advax had higher serum neutralisation titres than those immunised with ccJE alone or with alum adjuvant. ccJE+Advax induced extraordinarily broad cross-neutralising antibodies against multiple flaviviruses including West Nile virus (WNV), Murray Valley encephalitis virus (MVEV), St Louis encephalitis virus (SLEV) and Dengue virus-1 and -2 (DENV-1 and -2). Notably, the DENV-2 cross-neutralising antibodies from ccJE+Advax immunised mice uniquely had no DENV-2 antibody-dependent infection enhancement (ADIE) activity, in contrast to high ADIE activity seen with DENV-1 cross-reactive antibodies induced by mbJE or ccJE alone or with alum adjuvant. JEV-stimulated splenocytes from ccJE+Advax immunised mice showed increased IL-17 and IFN-γ production, consistent with a mixed Th1 and Th17 response, whereas ccJE-alum was associated with production of mainly Th2 cytokines. In a mouse lethal challenge study against highly virulent JaTH160 JEV strain, ccJE+Advax conferred complete protection in a two-dose schedule with 50 ng of vaccine antigen and near complete protection after a single 200 ng dose of vaccine antigen. There is an ongoing lack of human vaccines against particular flaviviruses, including WNV, SLEV and MVEV. Given its ability to provide single-dose JEV protection and induce broadly neutralising antibodies devoid of ADIE activity, ccJE+Advax vaccine could be useful in situations where rapid protection is desirable, e.g., during a local outbreak or for use in travellers or armies requiring rapid deployment to JEV endemic regions.Tomoyoshi KomiyaYoshikazu Honda-OkuboJeremy BaldwinNikolai PetrovskyMDPI AGarticleJapanese encephalitisvaccinesingles dose protectionflavivirusesantibody-dependent enhancementAdvaxMedicineRENVaccines, Vol 9, Iss 1235, p 1235 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Japanese encephalitis vaccine singles dose protection flaviviruses antibody-dependent enhancement Advax Medicine R
spellingShingle	Japanese encephalitis vaccine singles dose protection flaviviruses antibody-dependent enhancement Advax Medicine R Tomoyoshi Komiya Yoshikazu Honda-Okubo Jeremy Baldwin Nikolai Petrovsky An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection
description	ccJE+Advax is an inactivated cell culture Japanese encephalitis (JE) vaccine formulated with Advax, a novel polysaccharide adjuvant based on delta inulin. This vaccine has previously shown promise in murine and equine studies and the current study sought to better understand its mechanism of action and assess the feasibility of single dose vaccine protection. Mice immunised with ccJE+Advax had higher serum neutralisation titres than those immunised with ccJE alone or with alum adjuvant. ccJE+Advax induced extraordinarily broad cross-neutralising antibodies against multiple flaviviruses including West Nile virus (WNV), Murray Valley encephalitis virus (MVEV), St Louis encephalitis virus (SLEV) and Dengue virus-1 and -2 (DENV-1 and -2). Notably, the DENV-2 cross-neutralising antibodies from ccJE+Advax immunised mice uniquely had no DENV-2 antibody-dependent infection enhancement (ADIE) activity, in contrast to high ADIE activity seen with DENV-1 cross-reactive antibodies induced by mbJE or ccJE alone or with alum adjuvant. JEV-stimulated splenocytes from ccJE+Advax immunised mice showed increased IL-17 and IFN-γ production, consistent with a mixed Th1 and Th17 response, whereas ccJE-alum was associated with production of mainly Th2 cytokines. In a mouse lethal challenge study against highly virulent JaTH160 JEV strain, ccJE+Advax conferred complete protection in a two-dose schedule with 50 ng of vaccine antigen and near complete protection after a single 200 ng dose of vaccine antigen. There is an ongoing lack of human vaccines against particular flaviviruses, including WNV, SLEV and MVEV. Given its ability to provide single-dose JEV protection and induce broadly neutralising antibodies devoid of ADIE activity, ccJE+Advax vaccine could be useful in situations where rapid protection is desirable, e.g., during a local outbreak or for use in travellers or armies requiring rapid deployment to JEV endemic regions.
format	article
author	Tomoyoshi Komiya Yoshikazu Honda-Okubo Jeremy Baldwin Nikolai Petrovsky
author_facet	Tomoyoshi Komiya Yoshikazu Honda-Okubo Jeremy Baldwin Nikolai Petrovsky
author_sort	Tomoyoshi Komiya
title	An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection
title_short	An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection
title_full	An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection
title_fullStr	An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection
title_full_unstemmed	An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection
title_sort	advax-adjuvanted inactivated cell-culture derived japanese encephalitis vaccine induces broadly neutralising anti-flavivirus antibodies, robust cellular immunity and provides single dose protection
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/3410be75772e476ab3979476c60a7d80
work_keys_str_mv	AT tomoyoshikomiya anadvaxadjuvantedinactivatedcellculturederivedjapaneseencephalitisvaccineinducesbroadlyneutralisingantiflavivirusantibodiesrobustcellularimmunityandprovidessingledoseprotection AT yoshikazuhondaokubo anadvaxadjuvantedinactivatedcellculturederivedjapaneseencephalitisvaccineinducesbroadlyneutralisingantiflavivirusantibodiesrobustcellularimmunityandprovidessingledoseprotection AT jeremybaldwin anadvaxadjuvantedinactivatedcellculturederivedjapaneseencephalitisvaccineinducesbroadlyneutralisingantiflavivirusantibodiesrobustcellularimmunityandprovidessingledoseprotection AT nikolaipetrovsky anadvaxadjuvantedinactivatedcellculturederivedjapaneseencephalitisvaccineinducesbroadlyneutralisingantiflavivirusantibodiesrobustcellularimmunityandprovidessingledoseprotection AT tomoyoshikomiya advaxadjuvantedinactivatedcellculturederivedjapaneseencephalitisvaccineinducesbroadlyneutralisingantiflavivirusantibodiesrobustcellularimmunityandprovidessingledoseprotection AT yoshikazuhondaokubo advaxadjuvantedinactivatedcellculturederivedjapaneseencephalitisvaccineinducesbroadlyneutralisingantiflavivirusantibodiesrobustcellularimmunityandprovidessingledoseprotection AT jeremybaldwin advaxadjuvantedinactivatedcellculturederivedjapaneseencephalitisvaccineinducesbroadlyneutralisingantiflavivirusantibodiesrobustcellularimmunityandprovidessingledoseprotection AT nikolaipetrovsky advaxadjuvantedinactivatedcellculturederivedjapaneseencephalitisvaccineinducesbroadlyneutralisingantiflavivirusantibodiesrobustcellularimmunityandprovidessingledoseprotection
_version_	1718410206482792448

An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection

Ejemplares similares